Balancing act: counteracting adverse drug effects on the microbiome

Area of Science:

• Microbiology
• Pharmacology
• Host-Microbe Interactions

Background:

• The human gut microbiome, a complex microbial ecosystem, is integral to host health and wellbeing.
• Drug treatments can disrupt the gut microbiome, leading to adverse health outcomes like infections and metabolic disorders.
• Despite vulnerability, the microbiome's adaptability offers potential for therapeutic interventions.

Purpose of the Study:

• To review innovative approaches for minimizing drug-induced damage to the gut microbiome.
• To discuss the application of these strategies in various clinical contexts.
• To identify challenges and future directions for microbiome protection.

Main Methods:

• Literature review of recent studies on microbiome protection strategies.
• Analysis of emerging therapeutic approaches targeting drug-induced microbiome alterations.
• Discussion of clinical applicability and challenges.

Main Results:

• Several innovative strategies are being developed to mitigate collateral damage to the gut microbiome from medications.
• These approaches show promise in preventing, protecting, or reversing drug-induced microbiome dysbiosis.
• The review highlights the need for further research into effective microbiome protection.

Conclusions:

• Protecting the gut microbiome from drug-induced damage is crucial for host health.
• Emerging strategies offer promising avenues for preserving microbiome integrity during medical treatments.
• Further research and development are needed to translate these approaches into clinical practice.